Genuity Science Investor

Some of the world's most advanced clinico-omic data and insights to enable better disease discovery to improve human health.


Invests into

Funding Status: M&A
Headquarters: Boston, Massachusetts, United States
Zip: NA
Acquisitions Number: Made Acquisitions, Was Acquired
Founded Date: 2013-01-01
Employee Number: 101-250
Last Funding Type: Series C
Total Funding: 455000000.0
Estimated Revenue: $10M to $50M
Industry: End-to-End Drug Development
Investors Number: 8.0
Technology: Cancer
Last Funding Date: 2018-11-27